Cardiac Marker Analyzer Product Analysis, Business & Marketing Strategy of Cardiac Marker Companies - 2nd Edition
Buy Now
Updated report available here: https://www.renub.com/cardiac-marker-analyzer-worldwide-analysis-91-p.php
Cardiometabolic products and services provide timely cardiovascular and metabolic information at the point-of-care. Until today, Troponin and CK-MB were the lead cardiac markers. Brain Natriuetic Pepetide (BNP) was recently introduced to differentiate between a Myocardial Infarction and Heart Failure. The routine markers of myocardial infarction – CK-MB, Troponin and Myoglobin and recently BNP are used in the acute care and tests such as Cholesterol are used to evaluate risk. A number of companies are focused on developing new cardiac markers.
Alere delivers reliable and actionable health information through rapid diagnostic tests, resulting in better clinical and economic healthcare outcomes globally. Alere’s Cardiology net product sale was more than US$ 600 Million in 2016 and is expected to rule this industry in the future.
Updated report available here: https://www.renub.com/cardiac-marker-analyzer-worldwide-analysis-91-p.php
Beckman Coulter offers the maximum number of cardiac marker tests on its cardiology platform while Abbott Laboratories (i-Stat) and Siemens Healthineers (Stratus® CS Analyzer) also perform several cardiac marker tests on their cardio-metabolism platform and establishes them as the leader in this market.
Cardiac Markers Analyzers usually measure the levels of enzymes and proteins released from heart muscle when it is damaged. Physicians use cardiac markers in two ways – to diagnose a cardiac event in a hospital emergency room or within the hospital or to evaluate a risk of a cardiovascular event occurring.
Cardiac Marker Analyzer – Product Analysis, Business & Marketing Strategy of Cardiac Marker Companies is the 2nd report published by Renub Research. This 105 page report contains 14 Figures and 12 Tables provides a comprehensive analysis of the cardiac markers analyzer segments, including their comparative tests analysis, competitive product analysis, product features, merger, acquisitions, analyzer sales figures and Business and Market Strategies of Companies.
Updated report available here: https://www.renub.com/cardiac-marker-analyzer-worldwide-analysis-91-p.php
All the 12 Cardiac Marker Analyzers in the report have been studied from 5 viewpoints.
1. Analyzer Specifications and Benefits
2. Net Product Sales
3. Merger, Acquisition & Licensing Agreement
4. Marketing Strategies
5. Methods of Distribution
The 12 Cardiac Marker Analyzer studied in the report are as follows:
1. Alere Meterpro Analyzer
2. RAMP 200
3. RAMP Reader
4. The i–STAT System
5. Cobas h 232 POC System
6. Stratus CS Analyzer
7. Access 2 Immunoassay System
8. ichroma DUO Analyzer
9. DXpress Reader Analyzer
10. PATHFAST Analyzer
11. Meritas POC Analyzer
12. QL Care Analyzer
Updated report available here: https://www.renub.com/cardiac-marker-analyzer-worldwide-analysis-91-p.php
1. Executive Summary
2. Cardiac Marker Companies – Comparative Tests Analysis
3. Cardiac Marker Analyzer – Competitive Product Analysis
4. Alere
4.1 Alere Triage
4.1.1 Triage MeterPro Analyzer
4.2 Alere Cardiology Net Sales & Forecast (2011 - 2022)
5. Response Biomedical
5.1 Cardiovascular Testing
5.1.1 Acute Myocardial Infarction (Heart Attack) Testing
5.1.2 Congestive Heart Failure (“CHF”) Testing
5.1.3 Thrombotic Disease Testing
5.2 RAMP Platform
5.2.1 RAMP 200
5.2.2 RAMP Reader
5.3 Response Biomedical Cardiovascular Net Sales (2011 – 2022)
6. Abbott Point of Care
6.1 The i–STAT System
6.2 Abbott Laboratories Point of Care Diagnostics Sales (2011 – 2022)
7. Roche
7.1 Cobas h 232 POC System
8. Siemens Healthineers
8.1 Stratus CS Analyzer
8.2 Siemens Healthineers establishes global Digital Ecosystem to drive Digitalization of Healthcare
9. Beckman Coulter
9.1 Access 2 Immunoassay System
10. Boditech
10.1 i–chroma DUO Analyzer
11. Lifesign
11.1 DXpress Reader Analyzer
12. LSI Medience Corporation
12.1 PATHFAST Analyzer
13. Trinity Biotech
13.1 Meritas POC Analyzer
13.2 Trinity Biotech Point of Care Diagnostics Sales (2011 – 2022)
14. CardioGenics Holdings Inc.
14.1 QL Care Analyzer
15. Mergers, Acquisitions and Licensing Agreements
15.1 Alere Inc
15.2 Response Biomedical
15.3 Abbott Laboratories
15.4 Siemens Healthineers
15.5 LSI Medience Corporation
15.6 Trinity Biotech
15.7 CardioGenics
16. Emerging Markers
17. Response Biomedical – Business & Marketing Strategy
17.1 Reducing Research & Development (R&D) and Sales & Marketing Expenses under the Cost Reduction Strategy
17.2 New Distributors in China
17.3 Strategic Alliances with Alere Medical in Japan
17.4 Response Biomedical Receives Health Canada Approval and CE Mark
18. Roche – Business & Marketing Strategy
18.1 Implementing the Fully Connected Core Laboratory
18.2 Expansion of Rich Test Menu
18.3 Broadening the Diagnostics Portfolio
18.4 Patient Safety Comes First
19. Siemens Healthineers – Business and Marketing Strategy
19.1 Siemens Healthineers Announces New Strategic Relationship
19.2 Cloud-Based Network Teamplay from Siemens Healthineers
19.3 Strategic Partnership between Siemens and Imricor
19.4 Siemens Healthineers Offers True High-Sensitivity Troponin I IVD Assay
19.5 Siemens Healthineers & Digitalization
19.6 Partnership between Siemens Healthineers and Ebit
20. Boditech Med Inc – Business and Marketing Strategy
20.1 Boditech Med Acquires Immunostics
20.2 Strong Focus on Manpower and Investments in Research & Development Area
20.3 Advanced Technology in the Diagnostics Market
20.4 Marketing Channel
List of Figures
Figure 4 1: Worldwide – Alere Cardiology Net Sales (Million US$), 2011 – 2016
Figure 4 2: Worldwide – Forecast for Alere Cardiology Net Sales (Million US$), 2017 – 2022
Figure 5 1: Worldwide – Response Biomedical Cardiovascular Product Sales (Million US$), 2011 – 2016
Figure 5 2: Worldwide – Forecast for Response Biomedical Cardiovascular Product Sales (Million US$), 2017– 2022
Figure 6 1: Worldwide – Abbott Laboratories Point of Care Diagnostics Sales (Million US$), 2011 – 2016
Figure 6 2: Worldwide – Forecast for Abbott Laboratories Point of Care Diagnostics Sales (Million US$), 2017 – 2022
Figure 7 1: WIFI Set-up
Figure 7 2: QR CODE VIA BARCODE SCANNER Set-up
Figure 7 3: QR CODE VIA SMART PHONE APP Set-up
Figure 7 4: Connectivity of cobas h 232 in pre-hospital care and within hospital Set-up
Figure 13 1: Worldwide – Trinity Biotech Point of Care Diagnostics Sales (Million US$), 2011 – 2016
Figure 13 2: Worldwide – Forecast for Trinity Biotech Point of Care Diagnostics Sales (Million US$), 2017 – 2022
Figure 20 1: Boditech – R&D Manpower, Jan 2016
Figure 20 2: Boditech – R&D Investments (Million US$), Jan 2016
List of Tables
Table 2 1: Cardiac Marker Companies – Comparative Tests Analysis
Table 2 2: Cardiac Marker Companies – Comparative Tests Analysis
Table 2 3: Cardiac Marker Companies – Comparative Tests Analysis
Table 3 1: Cardiac Marker Analyzer – Competitive Product Analysis
Table 3 2: Cardiac Marker Analyzer – Competitive Product Analysis
Table 6 1: i-STAT 1 Analyzer Specification
Table 12 1: PATHFAST – Technical Specifications
Table 15 1: Mergers, Acquisitions and Licensing Agreements, 2003 - 2017
Table 18 1: Roche - Centralised and Point of Care Solutions Product Launches, 2017
Table 18 2: Roche - Molecular Diagnostics Product Launches, 2017
Table 18 3: Roche - Tissue Diagnostics Product Launches, 2017
Table 18 4: Roche - Sequencing Product Launches, 2017
Reach out to us
Call us on
USA: +1-678-302-0700
INDIA: +91-120-421-9822
Drop us an email at
info@renub.com